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Abstract	  	  
Background/Aims:	   There	   are	   compelling	   reasons	   to	   ensure	   participation	   of	   ethnic	  minorities	   and	   populations	   of	   all	   ages	   worldwide	   in	   nutrigenetics	   clinical	   research.	   If	  findings	  in	  such	  research	  are	  valid	  for	  some	  individuals,	  groups,	  or	  communities,	  and	  not	  for	  others,	  then	  ethical	  questions	  of	  justice	  –	  and	  not	  only	  issues	  of	  methodology	  and	  external	  validity	  –	  arise.	  This	  paper	  aims	  to	  examine	  inclusion	  in	  nutrigenetics	  clinical	  research	  and	  its	   scientific	   and	   ethical	   challenges.	  Methods:	   173	   publications	  were	   identified	   through	   a	  systematic	   review	   of	   clinical	   studies	   in	   nutrigenetics	   published	   between	   1998	   and	   2007.	  Data	   such	   as	   participants'	   demographics	   as	   well	   as	   eligibility	   criteria	   were	   extracted.	  
Results:	   There	   is	   no	   consistency	   in	   the	   way	   participants’	   origins	   (ancestry,	   ethnicity	   or	  race)	  and	  ages	  are	  described	   in	  publications.	  A	  vast	  majority	  of	   the	  studies	   identified	  was	  conducted	   in	  North	  America	  and	  Europe	  and	   focused	  on	   “white”	  participants.	  Our	   results	  show	  that	  pregnant	  women	  (and	   fetuses),	  minors	  and	   the	  elderly	   (≥75	  years	  old)	   remain	  underrepresented.	   Conclusion:	   Representativeness	   in	   nutrigenetics	   research	   is	   a	  challenging	  ethical	  and	  scientific	  issue.	  Yet,	  if	  nutrigenetics	  is	  to	  benefit	  whole	  populations	  and	   be	   used	   in	   public	   and	   global	   health	   agendas,	   fair	   representation,	   as	   well	   as	   clear	  descriptions	  of	  participants	  in	  publications	  are	  crucial.	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Introduction	  
	  The	   selection	   of	   participants	   in	   clinical	   studies	   is	   a	   crucial	   task.	   It	  may	   seem	   a	   truism	   to	  state	  that	  researchers	  must	  select	  a	  population	  sample	  that	  is	  appropriate	  to	  answer	  their	  research	  questions	  or	  hypotheses.	  And	  yet,	  this	  is	  a	  challenging	  task,	  in	  several	  respects.	  	  First,	  the	  selection	  of	  participants	  may	  be	  affected	  by	  competing	  interests:	  researchers	  may	  be	   torn	   between	   the	   desire	   to	   exclude	   individuals	   who	   could	   potentially	   bias	   the	   study	  results	  or	  decrease	   its	   statistical	  power,	   on	  one	  hand,	   and,	   on	   the	  other	  hand,	   the	   fear	  of	  compromising	   the	   validity	   and	   usefulness	   of	   their	   findings	   for	   a	   broader	   and	   general	  population	   (external	   validity).	   In	   all	   clinical	   studies,	   the	   choice	   of	   participants	   may	   be	  “heavily	  influenced	  by	  the	  wish	  to	  maximize	  the	  chance	  of	  observing	  specific	  clinical	  effects	  of	   interest”	   [1,	   p.	   4].	   In	   the	   same	   vein,	   overly	   strict	   eligibility	   criteria	   may	   affect	   the	  generalizability	   of	   findings,	   which	   mainly	   depends	   on	   the	   representativeness	   of	   study	  samples.	  As	  stated	  by	  Boushey	  et	  al.,	  “the	  difficulty	  with	  selecting	  a	  sample	  is	  ensuring	  that	  the	  sample	  is	  representative	  of	  the	  entire	  target	  population”	  [2,	  p.	  680].	  This,	  in	  turn,	  calls	  for	  an	  appropriate	  definition	  of	  a	  “target”	  population.	  	  Such	  methodological	   issues	   have	   been	  widely	   debated	   in	   the	   literature,	   in	  most	   fields	   of	  biomedical	   research,	   including	  clinical	  nutrition	  studies	   [2-­‐7].	  Nonetheless,	   controversy	   is	  particularly	  heated	  in	  genomics/genetics	  research.	  According	  to	  Janssens	  et	  al.,	  there	  is	  no	  single	   golden	   standard	  by	  which	  population	   and	   study	  design	   should	   be	   selected	   in	   such	  research.	  They	  stress	  that	  “the	  choice	  of	  the	  target	  population	  is	  not	  arbitrary,	  but	  rather	  is	  a	   trade-­‐off	   of	   the	   effectiveness,	   costs	   and	   harmful	   side	   effects	   of	   available	   interventions,	  among	   other	   factors”	   [8].	   In	   genetic	   studies,	   including	   genome-­‐wide	   association	   studies,	  algorithmic	  approaches	  have	  been	  developed	  to	  “stratify”	  populations	  in	  order	  to	  take	  into	  account	   variables	   or	   confounders	   that	   could	   affect	   the	   identification	   and	   the	   scope	   of	  genetic	  associations	  [9],	  as	  well	  as	  to	  preserve	  the	  external	  validity	  of	  the	  findings,	  despite	  population	   genetic	   diversity	   and	   admixture.	   The	   emergence	   of	   personalized	   health	  interventions	   –	   most	   often	   referred	   to	   as	   personalized	   medicine	   –	   as	   well	   as	   the	  development	  of	   genomic	   sciences	   in	  medical	   care	  –	  have	  dramatically	   revived	   the	  debate	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pertaining	   to	   the	   use	   of	   the	   concepts	   of	   “race”,	   “ancestry”	   and	   “ethnicity”	   (as	   proxies	   for	  genetic	   variations	   or	   predispositions,	   for	   instance)	   in	   clinical	   research	   and	   medical	  practices	   [9-­‐22].	   Yet,	   an	   attempt	   to	   synthesize	   or	   fully	   grasp	   the	  many	   controversies	   and	  issues	  that	  these	  concepts	  have	  generated	  would	  go	  beyond	  the	  scope	  of	  this	  paper.	  	  	  Beyond	   methodology	   and	   external	   validity	   issues,	   the	   definition	   of	   what	   constitutes	  appropriate	   representation	   in	   clinical	   research	   is	   further	   complicated	   by	   major	   ethical	  requirements	  and	  guidelines,	  and,	   in	  particular,	  by	   issues	  of	   justice	  and	  equity.	  For	  a	   long	  time,	  however,	  the	  principles	  of	  justice	  and	  equity	  in	  research	  ethics	  have	  centered	  on	  the	  prevention	   of	   exploitation	   and	   abuse	   of	   vulnerable	   individuals	   and	   populations	   (such	   as	  children,	   minorities,	   pregnant	   women,	   etc.).	   As	   such,	   ethical	   requirements	   linked	   to	   the	  justice	  principle	   focused	  on	   the	   risks	  of	  biomedical	   research	  rather	   than	  on	   fair	  access	   to	  clinical	  studies	  and	  appropriate	  representativeness	  [23].	  As	  a	  consequence,	  policies	  aiming	  to	   prevent	   the	   exploitation	   of	   individuals	   and	   populations	   in	   biomedical	   research	   had	   a	  pernicious	  effect:	   the	  protection	  afforded	  to	  vulnerable	  people	  has	  significantly	  prevented	  the	  latter	  from	  gaining	  a	  fair	  access	  to	  clinical	  studies.	  Yet,	  if	  results	  in	  biomedical	  research	  are	  valid	  for	  some	  individuals,	  groups,	  or	  communities,	  and	  not	  for	  others,	  then	  questions	  of	  fairness	  and	  justice	  –	  and	  not	  only	  issues	  of	  methodology	  and	  external	  validity	  –	  arise	  [24].	  An	  equitable	  selection	  of	  subjects	  in	  clinical	  research	  is	  thus	  crucial.	  	  Strategies,	   guidelines	   and	   policies	   designed	   to	   promote	   a	   greater	   justice	   in	   biomedical	  research	   and	   improve	   the	   representation	   of	   women,	   ethnic	   minorities,	   and	   children	   in	  clinical	   trials	   have	   been	   implemented	   in	   several	   Western	   countries	   [25-­‐32].	   Yet,	   recent	  studies	   indicate	   that	   such	   a	   representation	   is	   still	   limited	   despite	   regulations	   and	  recommendations	   [29,33].	   Moreover,	   it	   has	   been	   noted	   that	   discussion	   of	   diversity,	  inclusion,	   and	   representation	   in	   clinical	   research	   is	   often	  missing	   from	  published	   studies	  [29,34].	  	  	  In	   Canada,	   several	   articles	   of	   the	   Tri-­‐Council	   Policy	   Statement	   on	   Ethical	   Conduct	   for	  Research	   involving	  Humans	   (TCPS)	   [35]	   are	   inspired	   by	   distributive	   justice	   principles	   in	  biomedical	  research	  involving	  human	  beings.	  According	  to	  the	  Interagency	  Advisory	  Panel	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on	   Research	   Ethics,	   these	   provisions	   require	   that	   “[…]	   [t]he	   inclusion	   in	   research	   of	  participants	  representative	  of	  the	  general	  population	  should	  normally	  be	  respected,	  unless	  there	   is	   a	   valid	   reason	   for	   not	   doing	   so.	   […]	   those	   claiming	   a	   valid	   reason	   for	   excluding	  particular	   groups	   from	   research	   would	   bear	   the	   onus	   of	   persuading	   the	   REB	   [Research	  Ethics	  Board]	  of	  its	  validity.	  […]	  Overall,	  then,	  distributive	  justice	  norms	  in	  the	  TCPS	  should	  help	   the	   research	   community	   to	   design	   reasonable	   and	   scientifically	   grounded	   inclusion	  and	  exclusion	  criteria	  that	  strike	  a	  just	  balance	  for	  those	  participating	  in	  human	  research”	  [36].	  	  Although	  the	  issue	  of	  an	  equitable	  selection	  of	  subjects	  in	  clinical	  research	  has	  been	  much	  debated,	   the	   present	   paper	   aims	   to	   examine	   representativeness	   and	   some	   inclusion	   and	  exclusion	  criteria	  in	  nutrigenetics	  clinical	  studies,	  as	  well	  as	  the	  ethical	  challenges	  that	  they	  raise.	   With	   the	   introduction	   of	   genetic	   technologies	   and	   their	   application	   to	   nutritional	  sciences,	   the	   field	  of	  nutrigenomics	  and	  nutrigenetics	  developed	  rapidly.	  Considering	   that	  the	   terms	   “nutrigenomics”	  and	   “nutrigenetics”	  are	   frequently	  used	   interchangeably	   in	   the	  literature,	   in	   this	   paper,	   nutrigenomics	   is	   defined	   as	   the	   study	   of	   the	   variability	   of	   food-­‐genome	   interactions	   using	   information	   from	   the	   entire	   genome	   of	   an	   individual,	   while	  nutrigenetics	   refers	   to	   investigations	   on	   food	   interactions	   with	   specific	   candidate	   genes	  [37].	   However,	   definitions	   of	   nutrigenomics	   as	   opposed	   to	   nutrigenetics	   may	   remain	  controversial	  [37].	  	  	  Nutrigenetics	  information	  is	  expected	  to	  be	  relevant	  for	  treatment	  and	  also	  for	  prevention	  of	   chronic	   diseases,	   as	  well	   as	   for	   health	   promotion	   in	   the	   general	   population,	   including	  patients,	  at-­‐risk	  as	  well	  as	  healthy	  individuals.	  In	  terms	  of	  global	  health,	  both	  industrialized	  and	  emerging	   countries	   are	  now	   facing	   a	   growing	  epidemic	  of	   the	   same	   chronic	  diseases	  and	   have	   to	   cope	   with	   marked	   inequalities	   in	   healthcare	   access	   [38].	   In	   this	   context,	  nutrigenomics	  and	  nutrigenetics	  call	  for	  the	  right	  of	  whole	  populations	  to	  benefit	  from	  their	  results	   [38].	   How	   then	   to	   promote	   nutrigenetics	   research	   that	   would	   benefit	   all	  communities	   and	   populations?	   Like	   in	   biomedical	   research	   ethics	   in	   general,	   equity	   in	  research	  participation,	  just	  as	  fair	  and	  sound	  inclusion	  of	  subjects,	  should	  be	  pre-­‐requisites.	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Methodology	  
Sample	  and	  analysis	  We	  performed	   a	   systematic	   review	   of	   clinical	   studies	   in	   nutrigenetics	   and	   nutrigenomics	  published	   between	   1998	   and	   2007	   inclusively.	   Studies	   for	   potential	   inclusion	   were	  identified	   through	  a	  PubMed	  search.	  As	  nutrigenomics	   is	  a	   recent	  word	   that	  was	   indexed	  and	  introduced	  as	  a	  MeSH	  category	  encompassing	  nutrigenetics	  in	  PubMed	  only	  as	  of	  2008,	  we	   completed	   our	   search	  with	   different	   combinations	   of	   the	   following	   keywords:	   “food”,	  “nutrient”,	   “diet”,	   “gene”,	   “interaction”	   and	   “association”.	   The	   search	  was	   limited	   to	   titles	  and	   abstracts	   of	   original	   articles	   and	   reviews,	   commentaries	   and	   letters	   were	   excluded.	  Based	   on	   the	   NIH	   definition	   [39],	   all	   intervention	   and/or	   observational	   studies	   that	  involved	   human	   beings	   as	   participants	  were	   considered	   as	   clinical	   studies,	  while	   studies	  limited	   to	   the	   analysis	   of	   human	   cells	   or	   tissues	   only	   with	   no	   other	   active	   human	  participation	   than	   tissue	  or	   cell	  donation	  were	  excluded.	  Moreover,	   to	  be	   included	   in	  our	  sample,	   studies	   had	   to	  meet	   the	   following	   criteria:	   1)	   to	   have	   a	   specific	   gene	   component	  (e.g.,	  candidate	  gene	  or	  polymorphism),	  2)	  a	  dietary	  component:	  nutrient	  (from	  the	  diet	  or	  as	   a	   supplement),	   food,	  dietary	  pattern	   (e.g.,	  Mediterranean	  diet),	   etc.	   and	  3)	  describe	  an	  interaction	   between	   1)	   and	   2)	   that	   may	   impact	   health,	   disease	   onset,	   or	   nutritional	  biological	   pathways.	   A	   total	   of	   173	   studies	   met	   these	   criteria.	   These	   publications	  constituted	   the	   sample	   upon	   which	   we	   performed	   a	   detailed	   content	   analysis.	   The	   data	  extracted	   from	   these	   publications	   for	   use	   in	   the	   present	   paper	   were:	   a)	   authors'	  geographical	   location;	   b)	   participants'	   geographical	   location;	   c)	   participants'	   particulars,	  such	  as	  race,	  ethnicity,	  origin,	  nationality,	  ancestry,	  age,	   sex,	  comorbidities,	  and	  any	  other	  available	   data	   linked	   to	   participants'	   description,	   as	   well	   as	   any	   exclusion	   and	   inclusion	  criteria	   reported	   by	   the	   authors.	   The	   description	   of	   participants	  was	   completed	   in	  many	  cases	   with	   the	   tables	   provided	   by	   the	   authors	   to	   present	   their	   results.	   The	   following	  elements	   were	   also	   extracted	   from	   the	   publications	   of	   our	   sample:	   d)	   all	   authors'	  statements	  or	  comments	  about	  the	  potential	  or	  actual	  impact	  of	  genetic	  variations	  linked	  to	  ethnicity;	   e)	   all	   limitations	   of	   study	   results	   explicitly	   acknowledged	   and	   reported	   by	   the	  authors.	  It	  has	  to	  be	  noted	  that	  in	  120/173	  publications	  of	  our	  sample	  (hereafter:	  “referring	  
publications”),	   authors	   referred	   to	   previous	   publications	   and/or	   previous	   or	   ongoing	  studies	   (hereafter:	   “referred	  publications”)	   for	   the	  description	  of	   the	  methodology	  of	   their	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study,	   and/or	   of	   their	   participants	   or	   of	   their	   selection.	   Consequently,	   we	   consulted	   all	  
referred	  publications	   (≅190	  publications)	  to	  gather	  as	  much	  information	  as	  possible	  about	  participants’	  location,	  age,	  and	  ethnic	  origin.	  	  	  
Limitations	  Given	   the	   recent	   use	   of	   the	   terms	   “nutrigenomics”	   and	   “nutrigenetics”,	   the	   results	   of	   our	  search	  for	  clinical	  studies	  in	  this	  field	  is	  likely	  limited	  by	  the	  keywords	  (and	  combinations)	  that	   we	   chose.	   Nutrigenetics	   and	   nutrigenomics	   cover	   disparate	   fields	   and	   complex	  mechanisms	   that	   can	   be	   described	   in	   many	   different	   ways.	   Thus,	   our	   sample	   might	   not	  include	   all	   clinical	   studies	   that	   could	   have	   been	   identified	  with	   other	   keywords	   and	   that	  could	  have	  met	  the	  three	  selection	  criteria	  mentioned	  above.	  	  Studies	   that	   only	   measured	   gene	   expression,	   without	   pointing	   out	   and	   referring	   to	   a	  particular	  polymorphism	  or	  specific	  DNA	  sequence(s)	  or	  variation	  were	  also	  excluded.	  	  	  Finally,	   we	   could	   only	   identify	   participants’	   exclusion	   or	   inclusion	   criteria	   that	   were	  explicitly	   reported	   by	   the	   authors	   in	   their	   publications	   or	   that	   could	   be	   inferred	   from	  population	  sample	  descriptions	  such	  as	  provided	  in	  the	  publications.	  Yet,	  only	  a	  full	  review	  of	  research	  protocols	  could	  give	  a	  real	  picture	  of	  the	  explicit	  exclusion	  or	  inclusion	  criteria	  used	   in	   nutrigenetics	   research.	   As	   mentioned	   above,	   120	   publications	   referred	   those	  readers	  interested	  in	  getting	  more	  information	  about	  the	  participants	  or	  the	  methodology	  of	  the	  study	  to	  one	  or	  several	  previously	  published	  papers.	  Yet,	  30	  of	  these	  120	  publications	  provided	  us	  with	  one	  or	  more	  references	  which	  we	  could	  not	  access	  (e.g.,	  papers	  or	  books	  not	   accessible	   on	   the	   Internet	   or	  not	   accessible	  without	   fees	   from	   the	   electronic	   journals	  and	  library	  databases	  of	  our	  university).	  Moreover,	  14	  publications	  referred	  to	  an	  ongoing	  or	  previous	  study	  from	  which	  participants	  were	  recruited	  or	  in	  which	  participants	  took	  part	  but	  for	  which	  they	  did	  not	  provide	  any	  explicit	  reference	  in	  their	  bibliography.	  In	  4	  of	  these	  120	   publications,	   the	   references	   given	   for	   the	   description	   of	   the	   methodology,	   of	   the	  participants	   and/or	  of	   their	   selection	  were	   inaccurate	   (e.g.,	   reference	   to	   the	   abstract	   of	   a	  poster	   at	   a	   symposium,	   an	   incomplete	   reference,	   a	   reference	   to	   a	   theoretical	   paper	   that	  contributed	  no	  useful	  information	  about	  the	  participants	  of	  the	  referring	  study,	  etc).	  Finally,	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instead	  of	  providing	  the	  expected	  full	  description	  of	  the	  methodology	  of	  the	  study	  and/or	  of	  the	  participants,	  several	  referred	  papers	  turned	  to	  other	  previous	  publications	  for	  the	  same	  purpose	   (and	   in	   turn,	   some	  of	   the	   latter	  publications	   referred	   the	   readers	   to	  even	  earlier	  papers	  for	  the	  same	  descriptions).	  We	  did	  not	  extend	  our	  analysis	  of	  references	  beyond	  the	  references	  provided	  by	  referring	  publications.	  	  	  
	  
A.	  RESULTS	  	  
	  
1. Geographical	  location	  of	  participants	  and	  authors	  	  Of	   the	   173	   publications	   in	   our	   sample,	   participants’	   location	   was	   explicitly	   reported	   or	  could	   be	   inferred	   with	   certainty	   as	   being	   in	   Europe	   for	   73	   studies	   (42%),	   and	   North	  America	  for	  68	  studies	  (39%)	  (fig.	  1).	  The	  other	  studies	  were	  conducted	  with	  participants	  in	   Asia	   (17%)	   and	   Central	   America	   (5%).	   Our	   search	   parameters	   did	   not	   identify	   any	  publication	  explicitly	   reporting	  participants’	   location	   in	  Africa,	   South	  America	  or	  Oceania.	  The	  participants’	  location	  was	  not	  explicitly	  reported	  or	  could	  not	  be	  inferred	  with	  certainty	  in	  5	  cases	  (3%).	  	  	  A	   majority	   of	   studies	   was	   conducted	   by	   one	   –	   or	   more	   –	   researchers	   affiliated	   with	  institutions	   located	   in	   North	   America	   (excluding	  Mexico)	   (62%)	   and	   Europe	   (54%).	   Our	  data	  indicate	  that	  there	  are	  more	  studies	  with	  authors	  located	  in	  North	  America	  and	  Europe	  than	  studies	  with	  participants	   located	  in	  the	  same	  areas,	  which	  suggests	  a	  certain	   level	  of	  decentralization	  of	  nutrigenetics	  research	  (fig.	  1).	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Fig.	   1.	  Geographical	   location	   of	   participants	   and	   authors.	   Values	  were	   obtained	   from	   the	  whole	   sample	   of	  studies	  (n=173).	  Total	  of	  percentages	  is	  superior	  to	  100,	  as	  some	  studies	  were	  conducted	  on	  more	  than	  one	  continent	  and	  some	  publications	  had	  authors	  in	  more	  than	  one	  continent.	  A	  complete	  list	  of	  the	  countries	  of	  participants	  and	  authors	  is	  available	  in	  online	  supplementary	  table	  1.	  
	  
	  
2. Participants’	  “origin”	  	  Our	  sample	  of	  studies	  provides	  scant	  and	  often	  ambiguous	  information	  about	  participants'	  race,	   origin,	   ancestry	   or	   ethnicity.	   It	   appears	   that	   there	   is	   little	   coherence	   between	  publications	  in	  the	  way	  the	  terms	  race/ethnicity/ancestry/origin/	  and	  even	  nationality	  are	  used	   to	   describe	   sample	   populations	   (see	   table	   1	   and	   supplementary	   table	   2).	   In	   such	  circumstances,	   it	   is	   a	   challenging	   task	   to	   present	   our	   results	   in	   a	   coherent	   way	   and	   to	  understand	  what	  scope	  or	  meaning	  researchers	  attribute	  to	  the	  terms	  they	  use	  to	  describe	  their	  sample	  populations.	  Similarly,	  the	  way	  ethnicity,	  race,	  origin	  or	  ancestry	  was	  inferred	  or	  measured	   by	   researchers	   is	   rarely	   explicitly	   reported.	   For	   the	   purposes	   of	   this	   paper,	  given	   the	   lack	   of	   a	   consensual	   definition	   for	   such	   concepts	   as	   “race”,	   “ethnicity”	   or	  “ancestry”	   and	   the	   inconsistency	   in	   the	   use	   of	   such	   categories	   across	   studies,	   the	   term	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“origin”	  will	  be	  used	  to	  describe	  any	  mention	  relating	  to	  participants’	  ethnicity,	  race,	  origin,	  ancestry	  or	  nationality.	  	  
Table	   1.	   Participants’	   “origin”	   as	   reported	   in	   publications	   of	   studies	   in	  which	   the	  whole	  population	  sample	  is	  described	  as	  being	  of	  the	  same	  origin	  (i.e.	  non-­‐mixed	  studies)	  (n=88)	  
	  
Race/ethnicity1	   Nationality2	   Nationality	  &	  race/ethnicity3	   Ancestry
















Caucasians	  (1);	  Han	  Chinese	  (6);	  Japanese	  (5);	  Chinese	  (4);	  Mestizo	  (2);	  American-­‐Indians	  (1)	  
Portuguese	  (1);	  
Danish	  (2);	  Spanish	  
(2);	  British	  (1);	  
Finnish	  (2);	  Dutch	  
(1);	  Scottish	  (1);	  











Italian	  White	  (1);	  
White	  Americans	  




common	  to	  the	  
upper	  Midwestern	  
region	  of	  the	  US	  





All	  descriptions	  in	  bold	  font	  may	  be	  considered	  as	  referring	  to	  white/Caucasian	  participants	  (n=46).	  All	  samples	  that	  likely	  contained	  a	  majority	  of	  “white/Caucasian”	  participants	  appear	  in	  italic	  (n=13).	  This	  classification	  into	  5	  categories	  is	  adapted	  from	  Fullerton	  et	  al.	  [40].	  1The	  category	  “Race/Ethnicity”	  gathers	  descriptions	  of	  origins	  that	  explicitly	  used	  the	  terms	  “race”	  or	  “ethnicity”	  or	  that	  could	  be	  interpretatively	  linked	  to	  such	  concepts.	  While	  this	  classification	  is	  relatively	  straightforward	  for	  descriptions	  such	  as	  “Han	  Chinese”,	  “Caucasian”,	  “White”	  or	  “Hispanic	  Americans”,	  for	  instance,	  we	  are	  fully	  aware	  that	  descriptions	  such	  as	  “Japanese”,	  “Chinese”,	  “European	  American”	  or	  “French-­‐Canadian”	  could	  arguably	  be	  classified	  into	  other	  categories.	  However,	  a	  choice	  was	  made	  in	  each	  case	  considering	  other	  details	  provided	  in	  the	  publication:	  for	  instance,	  in	  one	  publication	  of	  our	  sample,	  participants	  were	  described	  as	  “patients	  who	  are	  at	  least	  75%	  Japanese	  […]”.	  2In	  at	  least	  20	  publications	  of	  non-­‐mixed	  studies	  (23%),	  participants’	  origin	  was	  described	  in	  terms	  of	  nationality	  only,	  with	  no	  explicit	  reference	  to	  “race”,	  “ethnicity”,	  “ancestry”	  or	  “origin”.	  	  3The	  column	  “Nationality	  &	  Race/Ethnicity”	  gathers	  the	  non-­‐mixed	  studies	  that	  combined	  both	  descriptions	  usually	  used	  to	  describe	  a	  race	  or	  an	  ethnicity	  and	  words	  denoting	  a	  nationality.	  4The	  category	  “Ancestry”	  lists	  descriptions	  that	  explicitly	  used	  the	  word	  “ancestry”.	  	  5Descriptions	  of	  origins	  that	  seemed	  to	  be	  mainly	  linked	  to	  a	  broad	  geographical	  location	  were	  grouped	  in	  the	  category	  “Geography”.	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Only	  in	  11	  publications	  of	  our	  sample	  (6%)	  did	  authors	  explicitly	  mention	  that	  ethnicity	  was	  self-­‐reported	  by	  participants.	  However,	  such	  an	  ethnicity	  inferring	  method	  was	  likely	  used	  in	   a	   majority	   of	   studies,	   through	   demographic	   questionnaires	   that	   were	   not	   always	  described	  in	  the	  publications.	  6	  studies	  of	  the	  whole	  sample	  (3%)	  explicitly	  mention	  the	  use	  of	  genomics	  tools	  such	  as	  HapMap	  data,	  but	  it	  is	  not	  clear	  in	  these	  cases	  to	  what	  extent	  such	  data	  were	  actually	  used	  in	  order	  to	  measure	  or	  validate	  participants’	  origin.	  	  	  Information	   about	   participants'	   origin	   could	   be	   found	   in	   124	   publications	   (72%),	   thus	  participants’	  origin	  could	  not	  be	  determined	  for	  49	  studies	  of	  our	  sample	  (28%).	  Included	  in	  the	   latter	   category	   are	   all	   publications	   that	   did	   not	   report	   any	   other	   information	   about	  participants’	  origin	  than	  the	  geographical	  location	  of	  the	  clinical	  research.	  	  Of	  these	  124	  publications,	  88	  studies	  (71%)	  involved	  participants	  who	  were	  all	  described	  as	  sharing	  the	  same	  origin	  (hereafter	  “non-­‐mixed	  studies”).	  Included	  in	  this	  group	  were	  all	  studies	   in	  which	  participants	  with	  a	  same	  origin	  were	  explicitly	  described	  as	  constituting	  “more	  than	  98%”	  of	  the	  sample,	  or	  in	  which	  participants	  were	  explicitly	  described	  as	  “all”,	  “nearly	  all”,	  “mainly”	  or	  “overwhelmingly”	  from	  the	  same	  origin.	  In	  these	  non-­‐mixed	  studies	  (n=88),	  we	  classify	  participants’	  origin	  descriptions	  according	  to	  5	  categories	  (adapted	  from	  Fullerton	  et	  al.	  [40];	  see	  table	  1).	  In	  the	  remaining	  36	  studies	  (i.e.,	  29%),	  population	  samples	  were	  explicitly	  described	  as	  being	  composed	  of	  groups	  of	  different	  origins	  (hereafter	  “mixed	  
studies”).	  As	  shown	  by	  Figure	  2A,	  89%	  of	  these	  studies	  (i.e.,	  32	  studies)	  included	  at	  least	  one	  “white”	  or	  “Caucasian”	  participant.	  “White”	  or	  “Caucasian”	  participants	  were	  not	  recruited	  
at	  all	  in	  4	  studies	  (11%)(fig.	  2A).	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Fig.	   2A.	   Ethnic	   representation	   in	   studies	   in	   which	   population	   sample	   is	   described	   as	   being	   composed	   of	  groups	  of	  different	  origins	  (mixed	  studies).	  Values	  are	  in	  percentages	  and	  were	  obtained	  from	  36	  non-­‐mixed	  studies.	  Note:	  While	  white/Caucasians	  were	  always	  explicitly	  named	  when	  represented	   in	   these	  36	  studies,	  there	  are	  13	  publications	  where	  the	  origin	  of	  the	  minority	  group	  was	  not	  described	  explicitly	  (e.g.,	  “other”	  or	  "unknown").	   Thus,	   the	   percentages	   indicated	   in	   this	   figure	   only	   take	   “explicit”	   descriptions	   of	   origins	   into	  consideration.	   Complete	   data	   are	   available	   in	   online	   supplementary	   table	   2.	   Fig.	   2B.	   Ethnic	   majorities	   in	  studies	  in	  which	  population	  sample	  is	  described	  as	  being	  composed	  of	  groups	  of	  different	  origins	  (i.e.	  mixed	  
studies).	  Values	  are	  in	  percentages	  and	  were	  obtained	  from	  the	  32	  mixed	  studies	  where	  the	  proportion	  of	  each	  ethnic	  group	  was	  provided.	  Complete	  data	  are	  available	  in	  online	  supplementary	  table	  2.	  	  Fig.	  2C.	  Participants'	  origin	   in	  studies	   in	  which	   the	  whole	  population	  sample	   is	  described	  as	  being	  of	   the	  same	  origin	  (non-­‐mixed	  
studies).	  Values	  are	  in	  percentages	  and	  were	  obtained	  from	  88	  non-­‐mixed	  studies.	  The	  category	  “Studies	  with	  white/Caucasians	  participants	  only”	  gathers	  the	  studies	  in	  which	  participants’	  origin	  was	  described	  with	  the	  words	  that	  appear	   in	  bold	   in	  table	  1.	  The	  category	  "Studies	  with	  a	  probable	  majority	  of	  "White/Caucasians"	  gathers	  the	  studies	  in	  which	  participants'	  origin	  was	  described	  with	  the	  words	  that	  appear	  in	  italic	  in	  table	  1.	  There	  is	  no	  study	  in	  which	  all	  participants	  were	  described	  as	  "Black",	  "African-­‐American"	  or	  "African".	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Figure	   2B	   and	   online	   supplementary	   table	   2	   provide	   a	   more	   complete	   picture	   of	   the	  different	   ethnic	   groups	   represented	   in	   all	   mixed	   studies.	   In	   32	   publications	   of	   36	  mixed	  studies	   (89%),	   authors	   reported	   the	   proportion	   (in	   percentages)	   of	   the	   participants	  belonging	  to	  the	  same	  ethnic	  group.	  Such	  information	  was	  not	  provided	  in	  4	  mixed	  studies	  (11%).	  In	  59%	  of	  the	  publications	  where	  the	  proportion	  of	  each	  ethnic	  group	  was	  provided	  (n=32),	   participants	   described	   as	   “white”	   or	   “Caucasians”	   constituted	   the	   majority	  (although	  this	  majority	  was	  low	  in	  3	  cases,	  where	  African-­‐Americans/blacks	  almost	  reached	  the	  same	  percentage)	  (fig.	  2B	  and	  online	  supplementary	  table	  2).	  	  	  Finally,	   our	   results	   indicate	   that	   of	   88	   non-­‐mixed	   studies,	   at	   least	   46	   (52%)	   involved	  white/Caucasian	  people	  only.	  This	  proportion	  is	  certainly	  higher,	  as	  participants	  described	  as	  “Danish”,	   “British”	  or	  “Scottish”,	   for	   instance,	  are	   likely	   in	  majority	  “white/Caucasians”.	  However,	   it	   cannot	   be	   inferred	   from	   such	   descriptions	   that	   it	   was	   the	   case	   for	   all	  participants.	   Figure	   2C	   summarizes	   these	   results:	   it	   shows	   that	   white/Caucasian	  populations	  are	  the	  most	  targeted	  ones	  in	  non-­‐mixed	  studies,	  while	  in	  our	  whole	  sample,	  not	  a	  single	  study	  involved	  exclusively	  black/African/Afro-­‐American	  participants.	  	  In	   summary,	  whatever	   the	  many	  ways	  used	   to	  designate	   “white”	  people	   (with	  potentially	  different	  descent	  or	  place	  of	  residency),	  our	  results	  show	  that	  they	  remain	  the	  most	  studied	  population.	  	  
3. Age	  of	  participants	  
	  Eligibility	  criteria	  relating	  to	  the	  age	  of	  the	  participants	  could	  be	  identified	  for	  106	  studies	  (61%	  of	  our	  whole	  sample).	  Thus,	  such	  criteria	  were	  not	  reported	  in	  67	  publications	  of	  our	  sample	  (39%).	  According	   to	   these	  criteria,	  people	  ≥75	  years	  old	  were	  not	  eligible	   in	  70%	  (n=74)	   of	   these	   106	   studies,	   and	   people	   <20	   years	   of	   age	   (minors,	   adolescents,	   children,	  infants)	  were	  not	  eligible	  in	  72%	  (n=76)	  of	  them.	  In	  comparison,	  people	  aged	  between	  40	  and	  49	  were	  eligible	  in	  86%	  of	  these	  studies	  while	  people	  aged	  between	  50	  and	  59	  in	  89%	  of	   them.	   Percentages	   decrease	   progressively	   after	   this	   age	   to	   reach	   15%	   for	   people	   aged	  ≥85	   years	   (data	   not	   shown).	  While	   eligibility	   criteria	   are	   crucial	   in	   order	   to	   address	   the	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ethics	  of	  fair	  inclusion	  in	  clinical	  research	  (see	  section	  “Discussion”	  below),	  they	  do	  not	  give	  a	  true	  picture	  of	  participants	  who	  were	  actually	  recruited	  into	  the	  studies.	  	  The	  mean	  age	  ±standard	  deviation	  (SD)	  of	  the	  participants	  who	  were	  actually	  recruited	  into	  the	  studies	  of	  our	  sample	  was	  reported	  or	  could	  be	  determined	  in	  146	  cases	  (84%	  of	  our	  whole	  sample;	  details	  can	  be	  found	  in	  the	  legend	  of	  figure	  3).	  A	  majority	  of	  the	  studies	  have	  included	  participants	  from	  the	  age	  categories	  of	  30-­‐39,	  40-­‐49,	  50-­‐59,	  60-­‐64,	  65-­‐69	  and	  70-­‐74	  years	  old	  (see	  percentages	  in	  the	  table	  of	  fig.	  3).	  A	  histogram	  in	  fig.	  3	  shows	  that	  in	  85%	  (124/146)	  of	  the	  studies	  in	  which	  mean	  age	  ±SD	  could	  be	  determined,	  the	  mean	  age	  of	  the	  sample	   for	   the	   population	   studied	  was	   between	  30	   and	  74.	   Thus,	   the	  majority	   of	   studies	  target	  individuals	  between	  30	  and	  74	  years	  of	  age.	  Conversely,	  a	  minority	  of	  studies	  focus	  on	  younger	  and	  older	  populations.	  Only	  15%	  of	  the	  studies	  have	  a	  mean	  age	  smaller	  than	  30	  years	  old	  and	  0%	  of	  studies	  have	  a	  mean	  age	  of	  70	  years	  old	  or	  more.	  	  Finally,	  it	  must	  be	  stressed	  that	  by	  reporting	  age	  distribution	  within	  2	  SD,	  we	  covered	  the	  inclusion	  of	  approximately	  95%	  of	  the	  participants	  in	  each	  study.	  Yet,	  according	  to	  a	  normal	  distribution,	  participants	  who	  are	  represented	  in	  an	  age	  category	  that	  lies	  within	  the	  second	  standard	  deviation	  from	  the	  mean	  only	  account	  for	  13.6%	  of	  the	  entire	  population.	  We	  did	  not	  take	  this	  into	  account.	  Moreover,	  as	  there	  are	  many	  cases	  where	  mean	  age	  ±	  2SD	  in	  a	  study	  did	  not	  encompass	  the	  whole	  age	  category	  interval	  located	  at	  its	  upper	  and	  lower	  limits,	  percentages	  of	  studies	  including	  participants	  of	  a	  given	  age	  category	  in	  the	  table	  of	  fig.	  3	  may	  be	  inflated	  and	  this	  limit	  is	  probably	  more	  important	  for	  the	  first	  and	  the	  last	  age	  categories	  included	  in	  the	  mean	  age	  ±2SD	  for	  each	  study.	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Figure	  3.	  Age	  of	   recruited	  participants.	  Each	  horizontal	   line	   represents	   the	  mean	   age	  ±	   2SD	  of	   the	   studied	  populations	  in	  one	  study,	  and	  therefore	  approximately	  the	  range	  of	  age	  of	  the	  participants	  [135].	  Values	  were	  obtained	   from	   the	   146	   studies	   in	  which	  mean	   age	  ±SD	  was	   reported	   or	   could	   be	   determined	   (84%	   of	   the	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whole	   sample).	   Mean	   age	   ±	   SD	   was	   not	   provided	   in	   28	   cases	   but	   could	   computed	   in	   8	   of	   these	   cases	   on	  aggregated	   data	   and	   extrapolated	   in	   the	   20	   remaining	   cases.	   In	   the	   latter	   cases,	   mean	   age	   ±SD	   was	  extrapolated	  on	  a	  presupposed	  normal	  distribution	  from	  the	  values	  provided	  in	  the	  publications	  such	  as	  age	  ranges	  for	  all	  participants	  or	  median	  age	  and	  IQR	  (e.g.,	  SD=IQR/1.34896	  and	  mean	  age=median	  age).	  The	  table	  on	   the	   bottom	   indicates	   the	   percentages	   of	   studies	   for	   which	   at	   least	   a	   part	   of	   the	   age	   range	   is	   in	   the	  corresponding	  age	  category.	  The	  histogram	  reports	  the	  number	  of	  studies	  in	  which	  participants’	  mean	  age	  is	  included	  in	  a	  given	  interval.	  The	  bold	  vertical	  line	  indicates	  the	  mean	  of	  all	  mean	  ages,	  i.e.,	  47	  years	  (“mean	  of	  the	  means”).	  	  	  	  
4. Source	  of	  study	  populations	  	  In	  103	  publications	  of	  our	  sample	  (59%),	  authors	  explicitly	  indicated	  that	  the	  participants	  of	  their	  study	  were	  already	  part	  of,	  or	  were	  recruited	   from,	  either	  a	  previous	  or	  an	  ongoing	  study	   (e.g.,	   EPIC,	   Framingham	   Offspring	   Study,	   Quebec	   Family	   Study,	   but	   also	   smaller	  studies).	   However,	   this	   number	   is	   actually	   higher,	   as	   some	   research	   groups	   who	   have	  several	  publications	  in	  our	  sample	  used	  the	  same	  cohorts	  without	  reporting	  it	  explicitly.	  	  	  
B.	  DISCUSSION	  	  
1.	  Participants’	  geographical	  location	  	  	  Beyond	   issues	   of	   ethnic	   representativeness	   in	   clinical	   research,	   the	   concentration	   of	  nutrigenetics	   studies	   in	   Europe	   and	  North	   America	   such	   as	   demonstrated	   by	   our	   results	  raises	  concerns	  in	  terms	  of	  equity	  and	  justice	  in	  biomedical	  research	  and	  global	  health.	  	  	  The	  inclusion	  of	  emerging	  countries	  in	  genomics	  and	  genetics	  research,	  as	  well	  as	  the	  global	  health	  applications	  expected	  to	  stem	  from	  this	  research,	  have	  been	  much	  debated	  [38,41-­‐43].	  While	  it	  is	  challenging	  to	  determine	  to	  what	  extent	  nutrigenetics	  could	  actually	  benefit	  emerging	  countries,	  in	  particular	  in	  its	  current	  –	  and	  still	  early	  –	  stage	  of	  development	  [38],	  it	   remains	   that	   chronic	   diseases,	   on	  which	  most	   current	   nutrigenetics	   studies	   focus	   (e.g.,	  cancer,	  diabetes	  and	  cardiovascular	  diseases),	  are	  still	  neglected	  in	  the	  global	  health	  agenda	  [44].	  Chronic	  diseases	   cannot	  be	   seen	  anymore	  as	  being	  prevalent	  only	   in	   rich	   countries:	  they	  will	  account	  for	  the	  most	  common	  causes	  of	  death	  by	  2015	  in	  both	  the	  developed	  and	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the	  developing	  world	  [45].	  Moreover,	  while	  underfeeding	  is	  still	  an	  important	  issue	  in	  many	  places,	   emerging	   economies	   are	   also	   grappling	   with	   malnutrition	   that	   has	   accompanied	  their	   nutrition	   transition	   and	   the	   global	   food	   crisis	   [46].	   Now,	   an	   increasing	   number	   of	  genomic	   and/or	   nutrition	   studies	   demonstrate	   the	   deep	   impact	   of	   early	   nutrition	   (be	   it	  underfeeding	  or	  malnutrition)	  on	  children's	  development	  and	  on	  their	  health	  as	  adults,	  as	  well	   as	   on	   future	   generations	   [47-­‐56].	   In	   this	   respect,	   nutrigenetics	   research,	   along	  with	  epigenetics	  research,	  could	  be	  a	  powerful	  tool	  notably:	  a)	  to	  understand	  the	  long-­‐term	  and	  intergenerational	   consequences	   of	   malnutrition	   and	   hunger	   worldwide;	   b)	   to	   develop	  potential	   preventative	   measures	   that	   could	   benefit	   both	   developed	   and	   developing	  countries;	  and	  c)	  to	  set	  up	  a	  shared	  agenda	  on	  research	  priorities.	  	  However,	   in	   order	   to	   achieve	   such	   goals	   and	   promote	   optimal	   health	   on	   a	   global	   scale,	  nutrigenetics	   research	   should	   also	   be	   conducted	   in	   developing	   countries,	   with	   local	  participants	   and	   local	   foodstuffs.	   Indeed,	   the	   usefulness	   and	   validity	   of	   research	   results	  obtained	   solely	   in	   industrialized	   countries	   may	   be	   limited	   to	   these	   countries.	   First,	   the	  micronutriment	   content	   and	  bioaccessibility	   of	   studied	   foodstuffs	  may	   vary	   considerably,	  depending	   notably	   on	   the	   place	   where	   such	   foods	   are	   grown	   (e.g.,	   [57-­‐60]).	   Second,	   the	  methods	   of	   diagnosis	   and	   management	   of	   diseases	   that	   are	   studied	   in	   nutrigenetics	  research	  may	  vary	   from	  one	   country	   to	   another	  and	   such	  differences	   in	   clinical	  practices	  may	   impact	   the	   external	   validity	   of	   clinical	   studies	   [61].	   Third,	   significant	   cultural	   and	  ethnic	   differences	   in	   eating	   habits,	   as	   well	   as	   in	   food	   production	   and	   preparation	   exist	  among	  nations	  [58,62].	  The	  processing	  and	  storage	  of	  foods	  may	  impact	  nutritional	  values	  and	   nutrient	   content	   of	   the	   food	   [63].	   Such	   differences	  may	   threaten	   the	   efficacy	   of	   any	  potential	   research	   result	   application	   or	   public	   health	   recommendations	   that	   would	   be	  based	  on	  clinical	  studies	  conducted	  solely	  in	  developed	  countries.	  	  Conducting	  nutrigenetics	   research	   in	  developing	   countries	   is	   certainly	   a	   challenging	   task.	  Financial	   limitations	   and	   resource-­‐limited	   settings	   constitute	   serious	   obstacles	   to	   such	  research.	  But	  it	  also	  raises	  important	  ethical	  issues.	  While	  many	  of	  the	  latter	  are	  common	  to	  any	  type	  of	  research	  in	  genetics	  (such	  as	  informed	  consent	  and	  privacy	  issues),	  others	  may	  arise	   specifically	   in	   nutrigenetics	   research	   [38]	   or	   with	   more	   acuteness	   in	   underserved	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countries	   or	   populations	   [64-­‐66].	   For	   instance,	   the	   evaluation	   of	   the	   impact	   of	   dietary	  programs,	   specific	   foodstuffs	   or	   lack	   of	   given	   micronutrients	   on	   genome	   expression,	  stability	  or	  integrity	  may	  be	  "stymied	  by	  the	  ethics	  of	  randomizing	  recipients"	  [67,	  p.	  1139]	  to	   a	   control	   group	   consisting	   of	   individuals,	  who	   like	  many	   others	   in	   the	   same	   region	   or	  country,	  are	  lacking	  access	  to	  basic	  nutrition	  (see	  [67]	  for	  an	  example	  of	  such	  an	  issue	  in	  a	  non-­‐genetic	   nutrition	   study).	   In	   any	   case,	   despite	   such	   challenges	   and	   obstacles,	   sound	  nutrigenetics	  research	  could	  eventually	  benefit	  emerging	  countries	  and	  global	  health,	  only,	  and	  only	  if,	  it	  is	  conducted	  also	  within	  their	  borders.	  	  
2.	  Participants’	  "origin"	  
	  Generalisability	  and	  external	  validity	  of	  clinical	  research	  results	  depend	  on	  an	  appropriate	  inclusion	   of	   all	   groups	   worldwide.	   In	   genomics	   and	   genetics	   research	   in	   particular,	   any	  limitation	  in	  the	  representativeness	  of	  population	  diversity	  may	  have	  a	  considerable	  impact	  on	  results.	   In	  this	  respect,	   it	   is	  worth	  stressing	  that	  the	  frequency	  of	  genetic	  variants	  may	  not	   only	   differ	   substantially	   between	   populations	   or	   ethnic	   groups	   (e.g.,	   [68]),	   but	   also	  within	  such	  populations	  or	  groups	  (e.g.,	  [69,70]).	  “Therefore,	  before	  appropriate	  genotyping	  panels	   can	   be	   established,	   the	   extent	   of	   functional	   genetic	   variation	   in	   candidate	   genes	  needs	   to	   be	   determined,	   especially	   in	   understudied	   populations”	   [71,	   p.	   340].	   Thus,	   the	  assumption	   that	   the	   discovery	   of	   common	   genetic	   variants	   and	   patterns	   in	   some	  populations	   will	   benefit	   all	   populations	   or	   all	   people	   in	   a	   given	   population	   is	   far	   from	  shared	   by	   everyone.	   The	   impact	   of	   admixture	   in	   populations	   and	   genomic	   variability	   on	  research	  results	  –	  as	  well	  as	  the	  efficacy	  of	  the	  methodological	  tools	  used	  to	  overcome	  such	  issues	   –	   remain	   controversial.	   The	   debate	   is	   particularly	   fierce	   in	   pharmacogenomics,	  genetic	  association	  studies	  and	  genome-­‐wide	  association	  studies,	  especially	  when	  it	  comes	  to	  using	   race,	   ancestry	  or	  ethnicity	  as	  proxies	   for	  genotype	   [8-­‐10,17,20,72-­‐75].	  But	   it	  has	  become	   clear	   that	   caution	   is	   needed	   when	   generalizing	   genetic	   research	   findings	   across	  ethnic	  populations	  (e.g.,	  [76]).	  	  	  In	  nutrigenetics,	  researchers	  face	  identical	  issues.	  As	  stated	  by	  Lewis	  and	  Burton-­‐Freeman,	  and	  demonstrated	  by	  our	  results,	  studied	  populations	  are	  often	  restricted	  to	  one	  ancestral	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or	  ethnic	  group	  and,	  as	  a	  consequence,	  the	  data	  “cannot	  be	  reliably	  applied	  to	  all	  individuals	  or	  other	  populations”	  [77,	  p.	  428S].	  In	  this	  respect,	  it	  is	  crucial	  to	  understand	  how	  prevalent	  a	   specific	   polymorphism	   involved	   in	   gene-­‐nutrient	   interactions	   has	   to	   be	   to	   warrant	  genotype-­‐specific	   recommendations	   for	   subgroups	   in	   the	   population	   (e.g.,	   [78,	   p.	   46]).	   In	  our	   sample,	   only	   48%	   of	   the	   publications	   mention	   or	   comment	   on	   the	   prevalence	   or	  frequency	  of	  studied	  polymorphisms.	  	  	  The	   challenges	   faced	   by	   researchers	   in	   nutrigenetics	   may	   be	   even	   greater	   than	   the	  aforementioned	  ones,	  as	  heterogeneity	  in	  study	  samples	  is	  not	  only	  introduced	  by	  genetics,	  but	  also	  by	  cultural	  factors.	  Indeed,	  there	  are	  major	  ethnic	  differences	  in	  dietary	  intake	  and	  food	   exposure	   that	   further	   complicate	   analysis	   [79,80].	   In	   other	   words,	   apart	   from	  controversies	   linked	   to	   the	   use	   of	   racial	   categories	   as	   proxies	   for	   genotypes,	   ethnicity	  matters	  in	  nutrigenomics,	  just	  as	  it	  does	  in	  any	  clinical	  nutrition	  research.	  It	  is	  therefore	  of	  the	   utmost	   importance	   to	   consider	   the	   influence	   of	   acculturation	   on	   diet	   and	   health,	   in	  particular	  when	   considering	   study	   result	   applications,	   whether	   it	   be	   to	   individuals	   or	   to	  whole	   populations	   [3].	   Moreover,	   ethnic	   differences	   may	   impact	   the	   validity	   of	   a	   food	  frequency	  questionnaire	  (hereafter:	  “FFQ”)	  results	  [81].	  Adaptation	  of	  such	  questionnaires	  to	   diverse	   cultural	   settings	   is	   certainly	   a	   challenge	   [82],	   all	   the	   more	   since	   cultural	  differences	   in	   dietary	   habits	   should	   not	   be	   reduced	   to	   ethnic	   categories	   either,	   given	   the	  many	  variations	  in	  dietary	  patterns	  that	  may	  also	  occur	  within	  ethnic	  groups.	  Yet,	  a	  lack	  of	  such	  adaptation	  may	  raise	  ethical	  issues	  in	  terms	  of	  justice	  and	  equity	  in	  access	  to	  research,	  in	  particular	  when	  participants	  who	  are	  unable	  to	  fill	  out	  questionnaires	  –	  an	  inability	  that	  may	  be	  caused	  by	  poorly	  adapted	  questionnaires	  –	  are	  excluded	  from	  an	  ongoing	  research	  project.	  Such	  an	  exclusion	  criterion	  was	  explicitly	  reported	  in	  11	  (6%)	  publications	  of	  our	  sample.	   It	   is	  worth	  noting	  that	  the	  use	  of	  a	  FFQ	  was	  reported	  in	  97	  publications	  (56%)	  of	  our	   whole	   sample,	   and	   25	   of	   them	   (26%)	   explicitly	   reported	   an	   adaptation	   of	   food	  questionnaires	   according	   to	   the	   ethnicity	   of	   the	   participants	   or	   to	   food	   customs	   in	   given	  areas.	   However,	   there	   is	   scarce	   information	   about	   the	   extent	   and	   the	   nature	   of	   such	  adaptations	  in	  the	  publications.	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Currently,	   nutrigenetics	   research	   is	   often	   limited	   to	   the	   study	   of	   the	   interactions	   of	   one	  single-­‐nucleotide	  polymorphism	  with	  one	  dietary	  component	  on	  one	  disease	  outcome	  [83],	  in	  a	  specific	  population.	  Our	  results	  consistently	  show	  that	  such	  research	  mainly	  focuses	  on	  “Caucasians”	   or	   “white”	   populations.	   Such	   limitations	   must	   be	   addressed	   and	   this	   will	  require,	   notably,	   analyses	   of	   gene-­‐food	   interactions	   in	   populations	   of	   varying	   ethnicities	  [58,79].	   There	   is	   another	   compelling	   reason	   to	   support	   a	   greater	   inclusion	   of	   ethnic	  minorities	  in	  nutrigenetics	  research.	  Ethnic	  minorities	  (as	  well	  as	  populations	  in	  developing	  countries	   and	   socio-­‐economically	  disadvantaged	  people)	   carry	  a	  disproportionate	  burden	  of	   chronic	  diseases	   [29,84],	   the	  same	  diseases	  on	  which	  many	  nutrigenetics	  studies	   focus	  (e.g.,	   cancer,	   diabetes	   and	   cardiovascular	   diseases).	   In	   such	   a	   context,	   a	   lack	   of	  representation	  of	  ethnic	  minorities	  may	  lead	  to	  an	  exclusion	  of	  people	  most	  likely	  to	  be	  in	  need	  of	  treatment	  or	  prevention	  measures	  resulting	  from	  the	  interventions	  or	  hypotheses	  being	  tested	  in	  such	  research.	  This	  may	  not	  only	  affect	  external	  validity,	  it	  also	  constitutes	  a	  serious	  concern	  about	   justice	  and	  equity	   in	  clinical	   research,	  and	  potential	  discrimination	  by	  unduly	  restricted	  access	  to	  medical	  research	  to	  those	  who	  would	  benefit	  the	  most	  from	  it.	  Thus,	  Ngo	  and	  colleagues	  suggest	  that	  studies	  in	  nutrition	  should	  not	  only	  include	  ethnic	  minorities	  and	  vulnerable	  populations,	  but	  even	  target	  them	  [6].	  	  	  We	   may	   note	   that	   our	   results	   indicate	   that	   ethnicity	   was	   explicitly	   reported	   as	   being	   a	  criterion	  for	  exclusion	  from	  the	  study	  or	  analyses	  in	  a	  few	  cases	  (6/173),	  and	  that	  in	  only	  one	  of	  these	  did	  the	  authors	  endeavor	  to	  explain	  the	  rationale	  behind	  the	  exclusion.	  In	  the	  latter	   case,	   the	   authors	   stated	   that	   “races	   other	   than	   white	   or	   African-­‐American	   were	  excluded	  from	  the	  analyses	  to	  reduce	  the	  potential	  variation	  in	  results	  by	  other	  races	  and	  because	  their	  numbers	  were	  too	  small	  to	  study	  separately”.	  Beyond	  rare	  explicit	  exclusions	  of	  certain	  ethnicities,	  our	  results	  indicate	  that	  in	  88	  studies	  of	  the	  124	  publications	  in	  which	  information	  about	  participants’	  origin	  was	  provided	  (51%),	  participants	  were	  described	  as	  belonging	  to	  one	  same	  origin	  (table	  1),	  and	   in	  59	  of	   these	  cases	  (67%),	  participants	  were	  certainly	   (52%)	   or	   likely	   (15%)	  white/Caucasians	   (fig.	   2C	   and	   table	   1).	   Our	   results	   also	  indicate	   that	   in	   mixed	   studies,	   white/Caucasian	   was	   the	   origin	   of	   the	   majority	   of	   the	  participants	  (fig.	  2B,	  and	  online	  supplementary	  table	  2).	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It	   remains	   crucial	   that	   all	   clinical	   research	   reports	   provide	   a	   clear	   description	   of	   their	  population	  samples.	  Our	  results	  indicate	  that	  in	  49	  publications	  of	  our	  whole	  sample	  (28%),	  we	   could	   not	   find	   any	   information	   about	   participants'	   origin	   including	   in	   referred	  publications	  (see	  Methodology).	  Moreover,	  in	  cases	  where	  such	  information	  was	  provided,	  precision	  was	  lacking	  in	  how	  terms	  like	  race,	  ancestry,	  or	  ethnicity	  were	  actually	  used	  and	  understood.	  Overall,	   it	   appears	   that	   there	   is	   a	  persistent	   inconsistency	   in	   the	  use	  of	   such	  categories	  across	  studies.	  Such	  findings	  are	  very	  similar	  to	  those	  reported	  by	  Fullerton	  and	  colleagues,	  who	  state	  that	  despite	  calls	  for	  greater	  clarity	  and	  precision	  in	  the	  description	  of	  the	  populations	  studied	  in	  genetic	  research,	  there	  is	  a	  documented,	  persistent	  ambiguity	  in	  the	   use	   of	   the	   terms	   race/ethnicity/ancestry	   [40].	   Descriptions	   in	   terms	   of	   nationality	  (which	   occur	   in	   20	   publications	   out	   of	   the	   124	   publications	   in	   which	   information	   about	  participants’	   origin	   was	   provided,	   i.e.,	   16%;	   see	   table	   1)	   are	   particularly	   uninformative	  about	   participants’	   origins	   and	   sometimes	   even	   troubling,	   such	   as	   was	   the	   case	   in	   two	  publications	  in	  which	  “women	  with	  non-­‐German	  nationality”	  were	  explicitly	  excluded	  from	  the	   study,	  or	  where	  all	  participants	  were	  described	  as	  being	   “born	   in	  Denmark”.	  Another	  example	  of	  striking	  ambiguity,	  found	  in	  2	  publications,	  is	  the	  breakdown	  of	  the	  participants	  into	   a	   “Jewish”	   group	   and	   a	   “Caucasian/white”	   one,	   as	   if	   such	   groups	   were	   necessarily	  distinct.	  	  	  This	  situation	  generates	  much	  concern	  both	  at	  a	  scientific	  and	  ethical	  level.	  Scientifically,	  an	  appropriate	   description	   of	   the	   participants	   in	   a	   study	   is	   needed	   to	   consider	   whether	  research	   findings	  may	  be	  generalized	   to	   the	  whole	  population	  or	  specific	  subgroups	  only.	  Appropriate	   representation	   of	   ethnic	   minorities	   in	   clinical	   research	   is	   an	   ethical	  requirement.	  Thus,	  exclusion	  from	  clinical	  research	  without	  appropriate	  reasons	  is,	  in	  itself,	  ethically	  problematic.	  	  Certainly,	   the	   inclusion	   of	   ethnic	   minorities	   in	   nutrigenetics	   research	   raises	   many	  challenges	  (see	  BOX	  1).	  But	  the	  exclusion	  of	  ethnic	  minorities	  motivated	  solely	  on	  the	  basis	  of	  such	  challenges	  are	  indefensible	  from	  an	  ethical	  standpoint	  [25,	  p.	  100].	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Box	  1	  
Challenges	  raised	  by	  the	  inclusion	  of	  ethnic	  minorities	  in	  nutrigenetics	  research	  
• The	   inclusion	   of	   ethnic	  minorities	   in	   nutrigenetics	   clinical	   studies	  may	   impact	   study	   results	   due	   to	  population	  stratification	  and	  other	  confounding	  factors,	  while	  the	  exclusion	  of	  ethnic	  minorities	  may	  affect	   the	   external	   validity	   of	   the	   study.	   Striking	   a	   balance	   between	   the	   two	   is	   difficult	   [86].	   Any	  exclusion,	  be	  it	  implicit	  or	  explicit,	  needs	  to	  be	  stated	  and	  justified	  scientifically	  and	  ethically.	  
• Defining	  an	  appropriate	  study	  population	  in	  terms	  of	  origin,	  race,	  ethnicity	  or	  ancestry	  is	  challenging	  in	  itself.	  Even	  in	  the	  United	  States,	  where	  it	  is	  a	  legal	  requirement	  for	  NIH-­‐funded	  studies	  [105],	  there	  is	   still	   much	   uncertainty	   about	   what	   constitutes	   an	   “appropriate”	   minority	   inclusion	   [106-­‐108].	  Moreover,	  there	  is	  still	  much	  confusion	  and	  ambiguity	  in	  the	  ways	  ethnicity,	  race	  or	  ancestry	  are	  to	  be	  understood,	   inferred,	   measured,	   assessed	   and	   reported	   [20,40,109].	   Yet	   inadequate	   reporting	   of	  ethnic	  representation	  may	  constitute	  a	  significant	  barrier	  to	  the	  assessment	  of	  the	  external	  validity	  of	  nutrigenetics	  research.	  	  
• The	  use	  of	  race,	  ethnicity	  or	  ancestry	  as	  a	  proxy	  for	  genotype	  remains	  highly	  controversial.	  Yet	  many	  commentators	   and	   scientists	   agree	   that	   the	   use	   of	   such	   categories	   may	   be	   deemed	   necessary	   in	  clinical	  research.	  As	  stated	  by	  the	  National	  Human	  Genome	  Research	  Institute,	  in	  all	  cases	  researchers	  should	  avoid	  overgeneralization	  by	  using	  population	  labels	  that	  are	  as	  specific	  as	  possible	  [110].	  	  
• Given	   the	   level	   of	   admixture	   –	   as	   well	   as	   differences	   in	   dietary	   patterns	   –	   in	   population	   groups	  themselves,	  we	  should	  not	  assume	  that	  variations	  in	  allelic	  frequencies	  or	  food	  habits	  actually	  reflect	  or	  could	  be	  reflected	  by	  racial	  or	  ethnic	  categories	  only	  (modified	  from	  Duster,	  [111]).	  	  
• Researchers	  should	  be	  ready	  to	  get	  involved	  in	  the	  debate	  surrounding	  the	  socio-­‐ethical	  issues	  linked	  to	   the	   potential	   resurgence	   of	   race	   as	   a	   biological	   concept,	   and	   the	   risks	   of	   discrimination	   and	  stigmatization	  that	  their	  study	  findings	  could	  raise	  [9-­‐22].	  	  
• There	   are	   documented	   barriers	   to	   the	   recruitment	   and	   retention	   of	  minorities	   in	   clinical	   research,	  including	   cultural	   gaps	   between	   researchers	   and	   participants,	   language	   issues,	   and	   costs.	   Yet,	  strategies	  exist	  to	  overcome	  such	  obstacles	  [29,112-­‐121].	  
• There	   are	   significant	   challenges	   to	   the	   assessment	   and	   measurement	   of	   dietary	   intake	   in	   ethnic	  minorities	  [6,81,122]	  and	  the	  adaptation	  of	  any	  FFQ	  to	  diverse	  cultural	  dietary	  habits	  [82].	  	  	  	  
3.	  Age	  of	  participants	  
	  The	  underrepresentation	   of	   elderly	   people	   and	   children	   (as	  well	   as	   infants	   and	  pregnant	  women)	   in	  biomedical	   research	  has	   received	  much	  attention	   in	   recent	   years.	  Evidence	  of	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the	  extent	  of	  this	  phenomenon	  and	  its	  potential	  impact	  has	  been	  reported	  and	  commented	  on	  by	  many	  authors,	  in	  various	  fields	  of	  clinical	  research	  [25,29,33,61,85-­‐90].	  
 Age	   does	   matter	   in	   nutrition	   research	   (e.g.,	   [91]).	   The	   proportion	   of	   elderly	   people	   is	  increasing	   in	   a	   significant	   manner	   in	   developed	   countries	   and	   this	   growth	   has	   serious	  implications	   for	   health	   care	   needs,	   public	   policy	   and	   research	   priorities	   [92].	   Yet,	   much	  remains	   to	  be	   learnt	  on	  elderly-­‐specific	  nutritional	  needs	  and	   the	   influence	  of	  diet	  on	   the	  aging	   process	   [93].	   Inadequate	   nutrition	   is	   a	   major	   problem	   affecting	   elderly	   people's	  health	  and	   it	  needs	   to	  be	   further	  studied	   [94,95].	  Similarly,	   several	  knowledge	  gaps	  were	  identified	   that	   pertained	   to	   infants',	   children's	   and	   adolescents’	   nutritional	   needs	   [78,	   p.	  170].	  	  	  Age	   also	   matters	   in	   genetics,	   including	   nutrigenetics.	   There	   are	   variations	   in	   gene	  expression	  across	  a	  lifespan	  [90].	  In	  addition,	  Qi	  and	  Liang	  stress	  that	  “the	  strength	  of	  both	  the	   genetic	   and	   dietary	   effects	   may	   change	   across	   life,	   and	   therefore,	   the	   gene-­‐diet	  interactions	  may	  be	  more	  likely	  to	  be	  identified	  at	  certain	  stages	  of	  life	  than	  others”	  [96,	  p.	  35].	   Thus,	   age	   should	   be	   considered	   as	   a	   significant	   factor	   in	   nutrigenetics	   interactions	  [83,97].	  Beyond	  the	  study	  of	  interactions	  between	  nutrients	  and	  genes	  themselves,	  research	  is	  now	  increasingly	  focusing	  on	  epigenetics/epigenomics	  mechanisms	  that	  may	  be	  affected	  by	  nutrition	  and	  that	  may	  have	  significant	   impacts	  at	  any	   life	  stage.	  A	  growing	  number	  of	  articles	  and	  reviews	  now	  debate	  and	  comment	  on	  the	  mechanisms	  that	  could	  explain	  how	  early-­‐life	   (including	   prenatal)	   nutrition	   can	   affect	   epigenetic	   mechanisms	   and,	   in	   turn,	  health,	  later	  in	  life	  [47,52-­‐56].	  In	  the	  same	  way,	  during	  aging,	  some	  genes	  may	  be	  aberrantly	  expressed	   due	   to	   altered	   epigenetic	   marks	   [98].	   At	   this	   stage,	   knowledge	   in	   this	   area	   is	  confined	   to	   proof-­‐of-­‐principle	   studies	   in	   animal	  models	   and	   very	   few	   and	   limited	   human	  studies	   [53,99].	   As	   a	   consequence,	   new	   knowledge	   gaps	   have	   been	   identified,	   with	   new	  research	  priorities	  such	  as	  the	  study	  of	  the	  variation	  of	  individual	  nutritional	  requirements	  brought	   on	   by	   epigenetics,	   lifestyle,	   environment,	   and	   geography	   [78,	   p.	   170]	   during	   the	  
course	  of	  a	  lifetime;	  the	  development	  of	  biomarkers	  of	  disease	  risk	  and	  interventions	  aiming	  to	  prevent	  or	  reverse	  the	  adverse	  effects	  of	  a	  poor	  early	  life	  environment	  [47,53];	  and	  the	  
	   24	  
identification	  of	  genes	  and	  pathways	  which	  are	  likely	  to	  be	  regulated	  epigenetically	  during	  aging	  and	  where	  effects	  of	  aging	  may	  be	  modulated	  by	  nutrition	  [98].	  	  The	  results	  of	  our	  analysis	  of	  published	  studies	  in	  nutrigenetics	  offer	  a	  valuable	  opportunity	  to	  consider	  the	  importance	  of	  age	  as	  a	  crucial	  variable	  in	  nutrigenetics	  studies,	  on	  one	  hand,	  and	  to	  address	  the	  need	  for	  a	  broader	  inclusion	  of	  participants	  of	  all	  ages,	  on	  the	  other.	  In	  the	   first	   place,	   our	   analysis	   shows	   that	   demographic	   characteristics,	   such	   as	   the	   age	  distribution	  of	  participants,	  were	  often	  poorly	  documented	  and	  it	  could	  not	  be	  ascertained	  in	   16%	   of	   the	   published	   articles	   in	   our	   sample.	   This	   lack	   of	   information	   about	   such	  demographic	  characteristics	  of	  the	  participants	  in	  publications	  is	  problematic,	  both	  in	  terms	  of	  science	  and	  ethics.	  Without	  such	  information,	  how	  can	  readers	  assess	  the	  scope	  and	  the	  utility	   of	   study	   results,	   as	  well	   as	   the	   representativeness	   of	   a	   sample	   population?	   In	   this	  context,	   it	   is	   crucial	   to	   acknowledge	   that	   any	   explicit	   or	   implicit	   exclusion	   of	   the	   elderly,	  pregnant	  women,	   infants,	   children	   and	   adolescents	   from	   clinical	   studies	   in	   nutrition	  may	  raise	   important	   ethical	   and	   scientific	   concerns	   –	   in	   particular	   if	   the	   rationale	   of	   such	   an	  exclusion	  is	  not	  carefully	  reported	  and	  clearly	  justified	  in	  research	  protocols.	  	  	  Our	  findings	  also	  clearly	  demonstrate	  that	  at	  this	  stage,	  nutrigenetics	  studies	  tend	  to	  focus	  on	  middle-­‐aged	  populations.	  Our	  results	  indicate	  that	  even	  without	  an	  explicit	  exclusion	  of	  elderly	   people,	   very	   few	   nutrigenetics	   studies	   focused	   on	   them	   (at	   least	   if	   elderly	   is	  >74	  years	  of	  age;	  see	  fig.	  3)	  This	  suggests	  that	  age-­‐based	  exclusions	  may	  not	  be	  planned	  in	  the	  formal	  study	  design	  but	  could	  be	  a	  result	  of	  other	  inclusion/exclusion	  criteria.	  First,	  the	  age	  of	  onset	  of	  most	  chronic	  diseases	  targeted	  by	  nutrigenetics	  research	  necessarily	  impacts	  the	  age	   distribution	   of	   participants.	   Second,	   exclusion	   criteria	   such	   as	   pre-­‐existing	   health	  problems,	  higher	  risk	  of	  comorbidities,	  intake	  of	  medications	  that	  could	  affect	  study	  results,	  potential	   cognitive	   impairments,	   and	   the	   exclusion	   of	   so-­‐called	   “unhealthy”	   participants	  from	   control	   groups	   inevitably	   restrict	   the	   elderly	   from	  participating	   in	   clinical	   research.	  Finally,	   it	  has	  also	  been	  argued	   that	  a	   limited	  representation	  of	  vulnerable	  populations	   in	  clinical	  research	  could	  also	  result	  from	  the	  characteristics	  of	  the	  recruitment	  procedures	  or	  even	  of	  a	  reluctance	  to	  recruit	  such	  populations	  [87].	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While	  the	  principle	  of	  justice	  requires	  a	  fair	  access	  to	  clinical	  research	  for	  all	  groups	  in	  the	  population,	   researchers	   and	   research	   ethics	   committees	   must	   also	   wonder	   whether	  exposing	   vulnerable	   populations	   to	   research	   procedures	   is	   ethically	   justified.	   Such	   a	  question	  cannot	  be	  answered	  without	  a	  sound	  review	  of	  the	  scientific	  validity	  of	  research	  protocols,	  as	  well	  as	  an	  appropriate	  assessment	  of	  the	  risks	  and	  the	  benefits	  of	  the	  research	  for	  the	  participants	  and	  the	  group	  they	  represent.	  	  	  In	   this	   respect,	   it	   is	   worth	   stressing	   again	   that	   “the	   ultimate	   goal	   of	   nutrigenomics	   is	   to	  determine	  the	  optimal	  nutrition	  for	  everyone,	  at	  any	  life	  stage”	  [78,	  p.	  163].	  This	  statement,	  as	   well	   as	   the	   aforementioned	   knowledge	   gaps,	   offer	   a	   solid	   rationale	   for	   a	   broader	  inclusion	   of	   pregnant	  women	   and	   fetuses,	   neonates,	   infants,	   children	   and	   adolescents,	   as	  well	  as	  the	  elderly,	  in	  nutrigenetics	  research	  projects,	  as	  is	  the	  case	  for	  many	  other	  fields	  of	  research.	  Yet,	  that	  does	  not	  imply	  that	  the	  recruitment	  of	  these	  populations	  in	  nutrigenetics	  studies	  would	  be	  relevant	  or	  feasible	  in	  all	  cases,	  given	  the	  current	  state	  of	  development	  of	  this	  new	  field	  of	  research	  and	  the	  various	  hypotheses	  or	  interventions	  that	  may	  be	  tested	  in	  these	  studies.	  But	  in	  any	  case,	  it	  cannot	  be	  assumed	  that	  genome-­‐nutrition	  interactions	  are	  negligible	  or	  of	  no	  interest	  for	  the	  elderly	  or	  the	  very	  young.	  If	  nutrigenetics	  research	  aims	  to	   develop	   and	   implement	   personalized	   nutrition	   interventions,	   it	   is	   legitimate	   to	   doubt	  that	  such	  a	  goal	  would	  cease	  to	  be	  relevant	  after	  a	  certain	  age.	  	  Certainly,	   research	   with	   the	   elderly,	   pregnant	   women	   and	   children	   may	   raise	   difficult	  practical,	  methodological	  and	  ethical	  challenges	  (BOX	  2).	  A	  full	  review	  of	  these	  difficulties	  would	  go	  beyond	  the	  scope	  of	  this	  paper.	  In	  any	  case,	  researchers	  should	  not	  avoid	  research	  that	   would,	   of	   necessity,	   include	   these	   populations,	   as	   a	   means	   of	   properly	   addressing	  research	  goals,	  simply	  to	  avoid	  such	  difficulties	  or	  the	  potentially	  more	  demanding	  ethical	  requirements.	  Research	  protocols	  should	  not	   include	  arbitrary	  age	  cutoffs	   [100,	  p.	  2],	  nor	  should	   age	   be	   used	   as	   a	   proxy	   for	   such	   conditions	   as	   cognitive	   impairment	   [25,	   p.	   8],	  incapacity	   to	   consent,	   or	   many	   current	   or	   potential	   comorbidities,	   nor	   as	   a	   proxy	   for	  difficulties	  in	  follow-­‐up	  or	  compliance.	  Therefore,	  research	  ethics	  committees	  should	  clearly	  challenge	  age-­‐based	  restrictions	   that	  are	  not	  scientifically	  grounded.	  As	  stated	  by	  Bartlett	  and	  colleagues,	  many	  commentators	  argue	  that	  the	  exclusion	  of	  elderly	  people	  from	  much	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medical	   research	   is	   not	   “good	   science”	   but	   discrimination	   against	   the	   old,	   which	   plays	   a	  significant	  part	   in	  sustaining	  differential	  opportunities	   to	  benefit	   from	  research	  [25,	  p.	  8].	  The	  same	  concerns	  may	  well	  be	  expressed	  regarding	  pregnant	  women	  and	  fetuses,	  infants,	  children	  and	  adolescents.	  	  
Box	  2	  
Challenges	  raised	  by	  the	  inclusion	  of	  the	  elderly,	  pregnant	  women,	  infants,	  children	  
and	  adolescents	  in	  nutrigenetics	  research	  
	  
• The	  obtention	  and	  quality	  of	  informed	  consent	  (and/or	  assent)	  from	  vulnerable	  populations	  is	  a	  well-­‐known	  issue	  [123-­‐127].	  
• Both	  the	  genetic	  testing	  of	  children	  and	  their	  participation	  in	  genetic	  research	  raise	  ethical	  concerns	  in	  terms	  of	  beneficence	  and	  protection	  of	  (future)	  autonomy	  [127,128].	  This	  is	  particularly	  true	  in	  nutrigenetics	  studies	  that	  would	  aim	  to	  investigate,	  in	  children,	  the	  precursors	  of	  adult	  complex	  late	  onset	  diseases	  or	  the	  potential	  heredity	   of	   epigenetics	   mechanisms.	   Data	   collection	   and	   storage	   procedures,	   protection	   of	   confidentiality,	  risks	  of	  discrimination	  and	  stigmatization	  must	  be	  considered	  and	  handled	  with	  care	  [126].	  	  
• The	   notion	   of	   minimal	   risk	   or	   acceptable	   burden	   in	   research	   involving	   vulnerable	   populations	   is	   still	  controversial	   [129,130].	   It	   is	   worth	   noting	   here	   that	   a	   rigorous	   evaluation	   of	   food-­‐health	   interactions	   and	  nutrition	   programs	   in	   children	   or	   the	   elderly	   may	   raise	   ethical	   conundrums,	   in	   particular	   when	   such	   an	  evaluation	  would	  require	  to	  randomize	  participants	  in	  a	  control	  group	  (e.g.,	  [67]).	  
• The	   validity	   and	   reliability	   of	   tools	   used	   to	   assess	   nutritional	   intake	   or	   behaviors	   in	   older	   participants	  [95,131],	  infants	  and	  children	  [78,132],	  or	  adolescents	  (e.g.,	  [132,133],	  as	  well	  as	  their	  recruitment	  [134]	  and	  compliance	  may	  also	  raise	  difficult	  practical	  and	  methodological	  challenges.	  
	  	  
4. Source	  of	  study	  populations	  
	  The	  frequent	  use	  of	  pre-­‐existing	  cohorts	  as	  a	  sample	  population	  may	  be	  problematic.	  Haga	  concisely	  described	  the	  issues	  at	  stake	  by	  stressing	  that	  “although	  convenient	  and	  likely	  to	  include	   detailed	   phenotypic	   data	   collected	   over	   a	   long	   period”,	   existing	   cohorts	   are	  most	  often	   representative	   of	   a	   single	   population	   only,	   “limiting	   the	   generalization	   of	   the	   study	  findings”	  [101,	  p.	  82].	  Haga	  also	  notes	  that	  “[m]any	  of	  the	  existing	  cohorts	  may	  have	  been	  established	  before	  federal	  [U.S.]	  efforts	  to	  bolster	  participation	  of	  women	  and	  minorities	  in	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  While	  nutrigenetics	  is	  still	  at	  the	  first	  stages	  of	  its	  development,	  it	  may	  impact	  every	  one	  of	  us,	   healthy	   or	   not,	   at	   any	   age.	   In	   such	   a	   context,	   the	   location	   where	   the	   studies	   are	  conducted,	  as	  well	  as	  the	  age	  and	  origin	  of	  participants,	  do	  matter	  and	  underrepresentation	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of	   certain	   groups	   of	   the	   population	   in	   nutrigenetics	   clinical	   research	   raises	   scientific	   and	  ethical	   concerns.	   Yet,	   as	   stressed	   by	   Bartlett	   and	   colleagues,	   “[i]n	   an	   ideal	   world,	   trial	  populations	  would	   reflect	   all	   those	   in	   need	   of	   the	   intervention	   being	   tested,	   but	   such	   an	  ideal	   is	  unlikely	   to	  be	  attainable	   in	  most	   instances”	   [25,	  p.	  103].	  This	  may	  be	  particularly	  true	   in	  nutrigenetics,	   given	   the	  many	   challenges	   raised	  by	   its	  methodological	   complexity.	  Such	  a	  complexity	  creates	  an	  inevitable	  tension	  between	  the	  aim	  to	  maximize	  the	  chances	  of	  observing	   significant	   nutrigenetics	   effects	   by	   excluding,	   from	   clinical	   studies,	   those	  individuals	   that	  could	  adversely	  affect	  results,	  on	  the	  one	  hand,	  and	  the	   ideal	  of	   justice	   in	  the	  research	  agenda	  as	  well	  as	  in	  the	  access	  to	  clinical	  research,	  on	  the	  other.	  Yet,	  in	  the	  long	  term,	  the	  underrepresentation	  of	  individuals	  from	  many	  countries,	  of	  ethnic	  minorities	  and	  of	   specific	   age	   categories	   in	   nutrigenetics	   research	   might	   threaten	   the	   efficiency	   of	   its	  expected	   applications	   in	   global	   and	   public	   health,	   creating	   “nutrigenetics”	   orphans	   and	  exacerbating	  health	  disparities.	  	  	  Certainly,	  individual	  researchers	  as	  well	  as	  research	  ethics	  boards	  do	  not	  have	  the	  power	  to	  ensure	   an	   appropriate	   representation	   of	   ethnic	   minorities	   and	   populations	   of	   all	   ages	  worldwide	  in	  the	  global	  nutrigenetics	  research	  agenda.	  However,	  both	  may	  participate	  in	  its	  promotion	  by	  designing,	  or	  reviewing	  with	  care,	  exclusion	  and	  inclusion	  criteria	  in	  research	  protocols.	  Any	  reasons	  for	  specific	  exclusions	  or	  inclusions	  should	  be	  explicitly	  stated	  and	  justified,	  ethically	  and	  scientifically.	  	  Despite	   their	   importance,	   eligibility	   criteria	   are	   often	   not	   reported	   adequately	   in	  publications	  [102,103].	  In	  addition,	  as	  eligibility	  criteria	  may	  not	  give	  a	  true	  picture	  of	  the	  participants	  who	  were	   actually	   recruited	   into	   clinical	   studies,	   one	   of	   the	  major	   concerns	  illustrated	   by	   our	   results	   is	   the	   confusion	   and/or	   lack	   of	   coherent	   information	   about	   the	  participants’	   demographics	   and	   the	   use	   of	   certain	   concepts	   such	   as	   race	   and	   ethnicity	   in	  clinical	   research	   reports.	   Clearly,	   complete	   and	   coherent	   reporting	   of	   such	   information	  remains	   crucial	   in	   order	   to	   assess	   the	   external	   validity	   of	   study	   findings,	   as	   well	   as	   the	  actual	   representation	   of	   diversity	   in	   nutrigenetics	   research.	   In	   this	   respect,	   editorial	  guidelines	   and	   other	   recommendations,	   such	   as	   the	   CONSORT	   statement	   [102]	   or	   ICH	  guidelines	  [104],	  if	  fully	  acknowledged	  and	  followed	  by	  authors	  as	  well	  as	  peer	  reviewers,	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may	  promote	  adequate	  reporting	  and	  thus	  increase	  awareness	  of	  the	  scientific	  and	  ethical	  issues	  at	  stake.	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Supplementary	  table	  1.	  Participants’	  and	  authors’	  geographical	  location	  by	  countries	  	  
	  
Continents	   Countries	  
Number	  of	  
studies1	  in	  which	  	  
participants	  are	  
located	  in	  the	  
specific	  
continent/country	  
mentioned	  on	  the	  
left	  
Number	  of	  studies1	  
in	  which	  authors	  
are	  affiliated	  with	  
an	  institution	  
based	  in	  the	  
specific	  
continent/country	  
mentioned	  on	  the	  
left	  
Asia	  
China	  (including	  Taiwan)	   14	   15	  Japan	   10	   11	  Singapore	   4	   5	  India	   1	   1	  
Central	  
America	  
Costa	  Rica	   7	   5	  Bahamas	   2	   0	  
Europe	  
United	  Kingdom	  (including	  Scotland)	   19	   22	  Spain	   13	   21	  The	  Netherlands	   12	   13	  Germany	   4	   5	  Denmark	   4	   4	  France	   4	   5	  Italy	  	   4	   5	  Finland	   3	   4	  Greece	   2	   2	  Poland	   2	   2	  Czech	  Republic	   2	   2	  Portugal	   1	   1	  Romania	   1	   1	  Russia	   1	   1	  Sweden	   1	   2	  Austria	   0	   1	  Switzerland	   0	   1	  Norway	   0	   1	  
North	  
America	  
USA	   53	   87	  Canada	   15	   21	  
Oceania	   Australia	   0	   1	  1Total	  number	  of	  studies=173.	  Same	  studies	  may	  involve	  participants	  as	  well	  as	  authors	  in	  different	  countries.	  	   Hurlimann	  et	  al.,	  2011	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Supplementary	  table	  2.	  Proportion	  of	  ethnic	  groups	  as	  explicitly	  reported	  in	  36	  mixed	  studies.	  	  
Ethnicity1	   %2	   Ethnicity	   %	   Ethnicity	   %	  
White	  Hispanic	  African-­‐American	   91	  4.5	  4.5	  
Caucasian	  African-­‐American	  Asian	  Others	  
63	  26	  5	  5	  
Other	  white	  Jewish	  French-­‐Canadian	  Others	  
60	  32	  5	  3	  Black	  White	   53	  47	   Caucasian	  African-­‐American	   77	  23	   White	  Others	   95	  5	  
Chinese	  Malays	  Asian-­‐Indian	   64	  21	  15	  
Hispanic	  (Puerto	  Rican	  descent)	  African-­‐American	  White	  
	  66	  32	  2	  
Japanese-­‐American	  White	  Latino	  African-­‐American	  Native	  Hawaiian	  Other	  
25	  22	  21	  19	  7	  6	  White	  African-­‐American	   51	  49	   Non-­‐Hispanic	  White	  Non-­‐Hispanic	  Black	  Others	   94	  3	  3	   Spanish	  settlers	  Indigenous	  Amerindians	  West	  Africans	   65	  28	  7	  Japanese	  Caucasian	  Native	  Hawaiian	   60	  26	  14	   Chinese	  Malays	  Asian-­‐Indian	   61	  22	  17	   Japanese	  Japanese	  American	   58	  42	  White	  (non	  Hispanic)	  Hispanic	  Black	  (non	  Hispanic)	   91.4	  4.4	  4.2	  
Caucasian	  African-­‐American	  Hispanic	  Asian	  
90	  6	  3	  1	  
Non-­‐Hispanic	  White	  Non-­‐Hispanic	  Black	  Mexican-­‐American	   39	  31	  30	  Caucasian	  African-­‐American	  Asian	  Native	  American	  Other	  heritages	  
65	  25	  5	  3	  2	  
Japanese-­‐American	  White	  Latino	  African-­‐American	  Native	  Hawaiian	  Other	  ethnic/racial	  origin	  
26	  23	  22	  16	  7	  6	  
Non-­‐Hispanic	  White	  Hispanic	  White	  Others	   60	  28	  12	  
Caucasian	  African-­‐American	  Hispanic	   92	  4	  4	   Hispanic	  White	  Non-­‐Hispanic	  White	   62	  38	   Latina	  White	  African-­‐American	   37	  34	  29	  White	  African-­‐American	  (Black)	   55	  45	   White	  Others	   86	  14	   African-­‐American	  White	   61	  39	  White	  Others	   98	  2	   Chinese	  Malays	  Indian	   61	  21	  18	   Caucasian	  Hispanic	  African-­‐American	   91	  4	  4	  Caucasian	  Jewish	  East	  Asian	  Others	  
84	  5	  4	  7	  
White	  African-­‐American	  Hispanic	  Asian	  Others/unknown	   n/a	  
African-­‐American	  Non-­‐Hispanic	  White	  	   n/a	  Mexican	  American	  Asian	  Caucasian	  African	  American	  Arabian	  
47	  25	  16	  9	  3	  
White	  Hispanic	  White	  non-­‐Hispanic	  Others	   n/a	   Hispanic	  Non-­‐Hispanic	  White	   n/a	  
1	  The	  “Ethnicity”	  column	  lists	  the	  different	  ethnic	  groups	  represented	  in	  each	  mixed	  study.	  2	  The	  “%”	  column	  indicates	  the	  proportion	  of	  each	  ethnic	  group	  in	  the	  sample	  of	  the	  study.	  	   Hurlimann	  et	  al.,	  2011	  
